Don’t take our word for it!
Read some of our Customer Stories
Radcliffe Group Ltd (RG) announces Wells Powell as Chief Technical Officer and Sean Delaney as Scientific Director
COVID-19 - The letter to the VP for Research
KIMT CBS News Jessica Bringe Reports on 122 Failure Modes Discovered in Heart Valves
Benefits of Open-Heart Repair Alternative Are Pumping Strong Growth
Combination Drugs and Novel Agents Are Driving Market
Increasing prevalence of cardiovascular diseases, increasing aging population, and growing acceptance of minimally invasive endovascular surgeries are expected to drive the market growth during the forecast period.
Program highlighted in new issue of Better Tennessee magazine
Announced by ingenious targeting laboratory
The Expert Network celebrates its newest member, Dr. Vilma I. Torres
Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure
Newest kit innovation expands commitment to continuous vascular access improvements
MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital
Deepak Srivastava, MD, led a team who created mouse models of CAVD that may be used to test drug therapies for the disease.
Lower stroke, mortality, renal failure, bleeding, atrial fibrillation, and length of intensive care unit stay with newer no-touch technique
Listed as Rising Star 2017